Enanta Pharmaceuticals, Inc.
ENTA
$13.85
$0.010.07%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 185.85M | 188.86M | 204.11M | 193.38M | 216.69M |
| Total Receivables | 8.49M | 6.88M | 8.36M | 40.63M | 40.16M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.34M | 8.59M | 10.24M | 8.86M | 10.68M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 608.00K |
| Total Current Assets | 198.68M | 204.34M | 222.71M | 242.86M | 268.15M |
|
|
|||||
| Total Current Assets | 198.68M | 204.34M | 222.71M | 242.86M | 268.15M |
| Net Property, Plant & Equipment | 71.31M | 72.94M | 74.87M | 76.68M | 77.04M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.45M | 3.45M | 3.45M | 3.46M | 3.45M |
| Total Assets | 329.50M | 280.73M | 301.03M | 322.99M | 348.64M |
|
|
|||||
| Total Accounts Payable | 1.89M | 1.95M | 3.55M | 4.76M | 4.73M |
| Total Accrued Expenses | 7.58M | 12.75M | 10.85M | 8.31M | 10.58M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 35.27M | 33.86M | 30.15M | 32.88M | 33.75M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 44.73M | 48.56M | 44.55M | 45.95M | 49.05M |
|
|
|||||
| Total Current Liabilities | 44.73M | 48.56M | 44.55M | 45.95M | 49.05M |
| Long-Term Debt | 104.13M | 112.44M | 121.29M | 126.73M | 131.09M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 53.78M | 54.76M | 55.66M | 56.54M | 56.45M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 269.00K | 260.00K | 252.00K | 243.00K | 235.00K |
| Total Liabilities | 202.91M | 216.02M | 221.75M | 229.46M | 236.83M |
|
|
|||||
| Common Stock & APIC | 543.79M | 469.99M | 465.91M | 461.74M | 457.18M |
| Retained Earnings | -416.87M | -404.93M | -386.23M | -367.97M | -345.33M |
| Treasury Stock & Other | -329.00K | -339.00K | -402.00K | -224.00K | -29.00K |
| Total Common Equity | 126.59M | 64.72M | 79.28M | 93.54M | 111.82M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 126.59M | 64.72M | 79.28M | 93.54M | 111.82M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 126.59M | 64.72M | 79.28M | 93.54M | 111.82M |
|
|
|||||